Literature DB >> 5002849

A comparison of the cardiovascular actions of daunomycin, adriamycin and N-acetyldaunomycin in hamsters and monkeys.

E Herman, R Mhatre, I P Lee, J Vick, V S Waravdekar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5002849     DOI: 10.1159/000136248

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


× No keyword cloud information.
  7 in total

1.  Inhibition of adriamycin cardiotoxicity by acetyldaunomycin.

Authors:  G Zbinden
Journal:  Experientia       Date:  1975-09-15

2.  Comparison of acute effects of anthracyclines on cardiac electrophysiological parameters of isolated guinea-pig hearts.

Authors:  G Stark; U Stark; H Samonigg; K Kasparek; A Lueger; S Nagl; H Bertuch; E Pilger; H A Tritthart
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Doxorubicin-induced hypotension in the beagle dog.

Authors:  E Herman; R Young; S Krop
Journal:  Agents Actions       Date:  1978-10

4.  Anthracycline-induced histamine release from rat mast cells.

Authors:  E A Riegel; M Kaliner; A N El-Hage; V J Ferrans; O Kawanami; E H Herman
Journal:  Agents Actions       Date:  1982-10

5.  Fisetin, a plant flavonoid ameliorates doxorubicin-induced cardiotoxicity in experimental rats: the decisive role of caspase-3, COX-II, cTn-I, iNOs and TNF-α.

Authors:  Tao Ma; Amit D Kandhare; Anwesha A Mukherjee-Kandhare; Subhash L Bodhankar
Journal:  Mol Biol Rep       Date:  2018-10-25       Impact factor: 2.316

6.  Protective effect of bilberry (Vaccinium myrtillus) against doxorubicin-induced oxidative cardiotoxicity in rats.

Authors:  Osama M Ashour; Ahmed A Elberry; Abdulrahman Alahdal; Ameen M Al Mohamadi; Ayman A Nagy; Ashraf B Abdel-Naim; Essam A Abdel-Sattar; Ahmed M Mohamadin
Journal:  Med Sci Monit       Date:  2011-04

7.  Protective Effect of Silymarin against Acrolein-Induced Cardiotoxicity in Mice.

Authors:  Elahe Taghiabadi; Mohsen Imenshahidi; Khalil Abnous; Fatemeh Mosafa; Mojtaba Sankian; Bahram Memar; Gholamreza Karimi
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-18       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.